The present study demonstrates an increased CX3CR1 expression in FH subjects, particularly in FH ATX+ subjects, supporting a possible involvement of monocyte CX3CR1 in subclinical atherosclerosis during pathological conditions such as hypercholesterolemia. The gene discussed is CX3CR1; the disease is atherosclerosis.